13F-HR filed by Seven Fleet Capital Management LP
Seven Fleet Capital Management LP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 114 holding rows worth $315,093,468.
- Accession
- 0001013594-26-000616
- Filer
- CIK 2092021
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 114 entries on the cover page, a total value of $315,093,468 stated on the cover page (in dollars after the unit check, H1), rows summing to $315,093,468 with VALUE read as dollars as filed, 13F file number 028-26709. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
Other managers
- included managerDV Trading LLC028-26555
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CG ONCOLOGY INC | 156944101 | COM | 1,439,393 | $97,418,118 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 502,012 | $10,502,091 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 80,792 | $7,857,022 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 195,685 | $7,494,736 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 187,876 | $7,090,440 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 209,547 | $7,088,975 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 2,947,826 | $6,662,087 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 164,030 | $6,429,976 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 108,450 | $6,302,029 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X110 | COM | 300,648 | $6,289,556 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 149,399 | $5,750,368 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F307 | COM NEW | 360,064 | $5,375,756 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380206 | COM NEW | 889,254 | $5,357,755 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 75,758 | $5,127,301 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 172,731 | $4,879,651 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 43,052 | $4,793,840 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 54,258 | $4,553,331 | dollars as filed | |
| PHARVARIS N V | N69605109 | COM | 143,966 | $4,067,040 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 61,269 | $4,038,240 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 115,770 | $3,875,980 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC | 29337E103 | COM | 95,253 | $3,733,918 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 222,468 | $3,599,532 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 128,168 | $3,550,254 | dollars as filed | |
| CYTOMX THERAPEUTICS INC. | 23284F106 | COM | 714,000 | $3,355,800 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 213,819 | $3,192,318 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 433,515 | $3,138,649 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 86,283 | $2,874,950 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 625,708 | $2,796,915 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 12,179 | $2,785,703 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 516,972 | $2,734,782 | dollars as filed | |
| DAMORA THERAPEUTICS INC | 36322Q206 | COMMON STOCK | 101,248 | $2,622,323 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 128,487 | $2,586,443 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 257,738 | $2,564,493 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 14,055 | $2,375,576 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B105 | COM | 423,566 | $2,240,664 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828109 | COM | 26,551 | $2,228,160 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P106 | COM | 276,000 | $1,998,240 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 99,887 | $1,887,864 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 69,571 | $1,884,678 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203310 | COM | 54,000 | $1,807,920 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 3,393 | $1,776,134 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 371,398 | $1,745,571 | dollars as filed | |
| LeonaBio Inc | 04746L203 | COM | 164,676 | $1,692,869 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 295,688 | $1,614,456 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 379,082 | $1,580,772 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 56,147 | $1,558,080 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T203 | COM NEW | 400,000 | $1,532,000 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 248,476 | $1,497,068 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 77,858 | $1,464,509 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 19,800 | $1,388,970 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 82,890 | $1,212,681 | dollars as filed | |
| VAXCYTE INC | 92243G109 | COM | 20,000 | $1,162,200 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 50,252 | $1,159,314 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 256,585 | $1,154,633 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 4,316 | $1,114,909 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 200,141 | $1,110,783 | dollars as filed | |
| LIPOCINE INC NEW | 53630X203 | COM NEW | 124,942 | $998,287 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 19,690 | $993,164 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 102,493 | $975,733 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 80,000 | $964,800 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 29,300 | $929,396 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 120,400 | $921,060 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 30,707 | $916,604 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 130,654 | $894,980 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 158,021 | $873,856 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 24,170 | $854,651 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 156,759 | $826,120 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 85,687 | $804,601 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 6,000 | $684,840 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 199,701 | $682,977 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 35,286 | $677,491 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 1,128 | $668,881 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 720 | $662,234 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 123,400 | $654,020 | dollars as filed | |
| LIQUIDIA CORPORATION | 53635D203 | COM NEW | 17,000 | $641,580 | dollars as filed | |
| GERON CORP | 374163103 | COM | 424,180 | $632,028 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 134,242 | $610,801 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 325,600 | $547,008 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 190,785 | $499,857 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 6,395 | $466,644 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 115,203 | $444,684 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 9,000 | $433,800 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 4,000 | $421,600 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 43,300 | $420,876 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 31,500 | $403,830 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 333,333 | $396,666 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 100,000 | $383,000 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 213,100 | $372,925 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 22,530 | $370,619 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 11,701 | $368,582 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y202 | COMMON STOCK | 55,700 | $366,506 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 27,054 | $353,325 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 27,149 | $323,887 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 78,057 | $320,814 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 4,300 | $309,385 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 38,100 | $292,227 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 11,445 | $275,023 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 31,296 | $265,077 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 110,000 | $257,400 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 16,671 | $231,727 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 205,542 | $228,152 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 2,072 | $212,276 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 8,804 | $209,800 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 3,231 | $206,590 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 54,296 | $187,321 | dollars as filed | |
| INHIBRX BIOSCIENCES INC | 45720N103 | COM | 2,482 | $166,865 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 1,969 | $165,731 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 57,076 | $150,110 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M505 | COM SHS | 10,600 | $134,620 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B107 | COM | 2,900 | $111,070 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 59,500 | $105,315 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 63,498 | $78,738 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 13,387 | $38,688 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,844 | $26,203 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001013594-26-000616 | this filing | 2026-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001013594-26-000652 | base | 2026-06-04 | acceptance time not in the bulk data set |